Hua Medicine (Shanghai) Ltd. logo

Hua Medicine (Shanghai) Ltd.

HKEX:2552.HK

Overview | Financials
Company Name Hua Medicine (Shanghai) Ltd.
Symbol 2552.HK
Currency HKD
Price 1.71
Market Cap 1,677,721,691
Dividend Yield 0%
52-week-range 1.03 - 2.65
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Li Chen Ph.D.
Website https://www.huamedicine.com

An error occurred while fetching data.

About Hua Medicine (Shanghai) Ltd.

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in

Related Stocks

Ascentage Pharma Group International logo

Ascentage Pharma Group International

6855.HK

41.05 HKD

Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited

1681.HK

8.61 HKD

Town Health International Medical Group Limited logo

Town Health International Medical Group Limited

3886.HK

0.248 HKD

Zylox-Tonbridge Medical Technology Co., Ltd. logo

Zylox-Tonbridge Medical Technology Co., Ltd.

2190.HK

11.02 HKD

Ascletis Pharma Inc. logo

Ascletis Pharma Inc.

1672.HK

1.58 HKD

Sisram Medical Ltd logo

Sisram Medical Ltd

1696.HK

3.6 HKD

MicroTech Medical (Hangzhou) Co., Ltd. logo

MicroTech Medical (Hangzhou) Co., Ltd.

2235.HK

4.54 HKD

Peijia Medical Limited logo

Peijia Medical Limited

9996.HK

3.92 HKD

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. logo

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

1558.HK

9.35 HKD

Antengene Corporation Limited logo

Antengene Corporation Limited

6996.HK

0.75 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD